title: [The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice].
authors.forename: V G
authors.initials: VG
authors.lastname: Kucherianu
authors.forename: V V
authors.initials: VV
authors.lastname: Iurasov
authors.forename: G N
authors.initials: GN
authors.lastname: Kryzhanovskiĭ
authors.forename: E V
authors.initials: EV
authors.lastname: Nikushkin
authors.forename: I V
authors.initials: IV
authors.lastname: Zhigal'tsev
authors.forename: V P
authors.initials: VP
authors.lastname: Kaplun
authors.forename: V I
authors.initials: VI
authors.lastname: Shvets
mesh_terms: D000818:Animals; D015259:Dopamine Agents / Q000008:administration & dosage*; D004337:Drug Carriers; D007980:Levodopa / Q000008:administration & dosage*; D008081:Liposomes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D015259:Dopamine Agents; D004337:Drug Carriers; D008081:Liposomes; D007980:Levodopa